Volume 4 Number 3
Website Exclusive Contents!
Editorial
EAPCI column
55
“Embargo” on scientific news, a late breaking message from the Ministry of Truth (MiniTrue)EuroInterv.2008;4:307-308
Focus article
56
Interventional cardiology highlights of the European Society of Cardiology congress, 2008EuroInterv.2008;4:309-310
Clinical research
57
Four-year safety and efficacy of the unrestricted use of sirolimus- and paclitaxel-eluting stents in coronary artery bypass graftsEuroInterv.2008;4:311-317
58
Characterisation of the “vulnerable” coronary plaque by multi-detector computed tomography:
a correlative study with intravascular ultrasound-derived radiofrequency analysis of plaque compositionEuroInterv.2008;4:318-323
59
Very late thrombosis in acute myocardial infarction: drug-eluting versus uncoated stentsEuroInterv.2008;4:324-330
60
The TandemHeart®, percutaneous transseptal left ventricular assist device: a safeguard in high-risk percutaneous coronary interventions. The six-year Rotterdam experienceEuroInterv.2008;4:331-337
61
Long-term safety and efficacy are observed after implantation of Zotarolimus-Eluting Stent in real-world clinical practiceEuroInterv.2008;4:338-344
62
“Gender paradox” in outcome after percutaneous coronary intervention with paclitaxel eluting stentsPresbitero P, Belli G, Zavalloni D, Rossi M, Lisignoli V, Barberis G, Gasparini G, Scatturin M, Morenghi E, Pagnotta P
EuroInterv.2008;4:345-350
63
Early echocardiographic evaluation following percutaneous implantation with the self-expanding CoreValve ReValving System aortic valve bioprosthesisde Jaegere P, Piazza N, Galema T, Otten A, Soliman O, Van Dalen B, Geleijnse M, Kappetein AP, García-García H, Van Es G-A, Serruys PW
EuroInterv.2008;4:351-357
64
The “mini-crush technique” for the treatment of coronary trifurcation lesionsEuroInterv.2008;4:358-364
65
Comparison of primary angioplasty in rural and metropolitan areas within an integrated networkGiuliani G, Bonechi F, Vecchio S, Biondi-Zoccai G, Nieri M, Vittori G, Spaziani G, Nassi F, Chechi T, Di Mario C, Zipoli A, Margheri M
EuroInterv.2008;4:365-372
66
Relationship between coronary and renal artery disease and associated risk factors in hypertensive and diabetic patients undergoing coronary angiographyEuroInterv.2008;4:373-377
Expert review
67
A primer on the immune system in the pathogenesis and treatment of atherosclerosisSegers D, García-García H, Cheng C, de Crom R, Krams R, Wentzel J, van der Steen A, Serruys PW, Leenen P, Laman J
EuroInterv.2008;4:378-390
Experimental research
68
Comparison of drug-eluting stent cell size using micro-CT: important data for bifurcation stent selectionEuroInterv.2008;4:391-396
How should I treat?
69
Stent migration as a late complication following carotid angioplasty and stentingCastriota F, de Campos Martins E, Dall'Olmo C, Molnar R, Manetti R, Liso A, Oshoala K, Furgieri A, Ricci E, Cremonesi A
EuroInterv.2008;4:397-404
Technical report
Volume 4 Number 3 has been released thanks to the support of the following partners:
- Abbott Vascular Devices
- Clearstream Technologies
- Cordis, a Johnson & Johnson company
- Hexacath
- Medtronic
- Terumo
- Zoll Medical Corporation


